Oxidative Stress Clinical Trial
— KMCOfficial title:
Impact of Kangaroo Mother Care on Selected Bio Marker and Maternal-Infant Bonding in Preterm Neonates in a Tertiary Care Hospital of Lahore, Pakistan
Verified date | March 2024 |
Source | University of Health Sciences Lahore |
Contact | n/a |
Is FDA regulated | No |
Health authority | |
Study type | Interventional |
The goal of this clinical trial is to learn if Kangaroo Mother care can have effect on oxidative stress in premature neonates. It will also learn about the bonding between mother and her premature infant. The main questions it aims to answer are: - Does Kangaroo mother care lower the biomarker of oxidative stress in premature neonates? - Is Kangaroo mother care associated with mother-infant bonding? Researchers will compare Kangaroo mother care to Conventional incubator care to see if Kangaroo mother care works to have effect on oxidative stress. Participants will be: - given Kangaroo mother care on third day of life or standard incubator care for one hour - Urine sample for oxidative stress biomarker will be collected via noninvasive method before and after Kangaroo mother care or conventional incubator care from premature neonates. - Mother-infant bonding scale will be filled by mothers of enrolled premature infants before and after kangaroo mother care and conventional incubator care
Status | Completed |
Enrollment | 40 |
Est. completion date | March 20, 2024 |
Est. primary completion date | March 20, 2024 |
Accepts healthy volunteers | No |
Gender | All |
Age group | 3 Days to 3 Days |
Eligibility | Inclusion Criteria: - For Pre-term Neonates: 1. 24-36 weeks' gestation Premature infants 2. Medically stable as determined by a Score of Neonatal Acute Physiology & Perinatal Extension (SNAPPE-II); pre-term neonates with score of less than 9. 3. Both gender 4. Weight 1.5kg to 2.499 kg For Mothers of Pre-term Neonates: 1. Medically stable Mothers. Exclusion criteria: The criteria for exclusion will be as follows: For Pre-term Neonates: Those will be excluded who are with below given conditions: 1. Require any kind of surgery. 2. Intraventricular hemorrhage (IVH) > or equal to grade 3. 3. On medication such as morphine, fentanyl, midazolam, muscle relaxants, phenobarbital. 4. Severe cyanotic heart disease or severe RDS. 5. Abdominal wall or intestinal anomaly or injury. 6. Chromosomal Disorder 7. Facial anomaly. For Mothers of Pre-term Neonates: 1. Mothers having Complications of delivery like Post partem hemorrhage. 2. Any acute illness 3. Complicated cesarean section |
Country | Name | City | State |
---|---|---|---|
Pakistan | Services Hospital, Lahore | Lahore | Punjab |
Lead Sponsor | Collaborator |
---|---|
University of Health Sciences Lahore | Services Hospital, Lahore |
Pakistan,
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | biomarker of Oxidative Stress (Allantoin) in urine sample of premature infants | Biomarker of oxidative stress (Allantoin) in urine samples of premature infants by ELISA Testing before and after one hour session of KMC by ELIZA testing | OnThird day of life before and after one hour of KMC or Conventional care | |
Primary | Mother- Infant Bonding | by Using Mother Infant bonding self rating scale (MIBS) of eight points descriptors bonding between mother and her infant will be measured. Total scores range from 0 to 24. A high score indicates worst mother to infant bonding. | OnThird day of life before and after one hour of KMC or Conventional care |
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT03255187 -
Effect of Dietary Supplemental Fish Oil in Alleviating Health Hazards Associated With Air Pollution
|
N/A | |
Completed |
NCT04136821 -
The Long-term Effects of Oceanix™ on Resistance Training Adaptations
|
N/A | |
Recruiting |
NCT03790345 -
Vitamin B6 and B12 in the Treatment of Movement Disorders Induced by Antipsychotics
|
Phase 2/Phase 3 | |
Completed |
NCT03358524 -
Effects of Vitamin E Supplementation on Free Radicals and Fat Level of Obese Adolescence in Jakarta, Indonesia
|
Phase 4 | |
Recruiting |
NCT05327348 -
Effectiveness of IV Vitamin C in Reducing Oxidative Stress Associated With Free Flap Surgery
|
Phase 3 | |
Completed |
NCT03288623 -
The Effects of Dark Chocolate Implementation in Elite Athletes
|
N/A | |
Completed |
NCT04419025 -
Efficacy of N-Acetylcysteine (NAC) in Preventing COVID-19 From Progressing to Severe Disease
|
Phase 2 | |
Completed |
NCT04597983 -
Effect of 8-week Intake of 2S-hesperidin on Performance, Body Composition and Biochemicals Markers in Amateur Cyclists
|
N/A | |
Not yet recruiting |
NCT06159543 -
The Effects of Fresh Mango Consumption on Cardiometabolic Outcomes in Free-living Individuals With Prediabetes
|
N/A | |
Enrolling by invitation |
NCT03030456 -
Whole Body Vibrations on Functional Capacity, Muscular Strength, and Biochemical Profile in Elders
|
N/A | |
Not yet recruiting |
NCT02202239 -
Effect of Induction and Maintenance of Anesthesia With Etomidate on Hemodynamics and Oxidative Stress in Diabetic Patients
|
Phase 4 | |
Completed |
NCT02256254 -
SIMOX - Induction of Oxidative Stress
|
Phase 2 | |
Recruiting |
NCT02048592 -
Impact of Immunonutrition on the Patients With Cystic Fibrosis
|
Phase 4 | |
Completed |
NCT01942460 -
Ferumoxytol for Iron-Deficiency Anemia in Chronic Kidney Disease and Peritoneal Dialysis Patients
|
Phase 4 | |
Completed |
NCT02463318 -
The Effect of Melatonin on Gene Expression and Activity of the Sirt1 and Its Target Genes Catalase and MnSOD in Multiple Sclerosis Patients and Healthy Subjects
|
N/A | |
Completed |
NCT02177383 -
Action of Essential Fatty Acids on the Expression of Antioxidant Genes and Athletic Performance
|
N/A | |
Completed |
NCT01990391 -
Brazil Nut Consumption in Microvascular Endothelial Function, Oxidative Stress and Metabolic Abnormalities
|
N/A | |
Completed |
NCT00845130 -
Quantitative in Vivo Biomarkers of Oxidative Stress in Diabetes
|
N/A | |
Completed |
NCT00607893 -
Efficacy of Continuous Positive Airway Pressure in Reducing Oxidative Stress in Individuals With Sleep Apnea
|
N/A | |
Active, not recruiting |
NCT00247507 -
The Effects of Acetylcysteine on Alleviating Damage of Oxidative Stress in Hemodialysis Patients
|
Phase 4 |